About Us
Investors Choice® Guidelines

What Are The Submission Guidelines?

Your company's submission to the Investors Choice® conference should closely adhere to the following guidelines in order to optimize the quality of our analysis of your plan, as well as improving the chances of you being selected to present at the event.

1. A Cover Page: Your summary must have a cover sheet complete with contact person, name of company, address, phone/fax numbers, e-mail, company URL and a 25-50 word description defining your business so that it can be used to publicize your company.

2. A Fact Sheet: When you register for Investors Choice® you will upload your summary to our AngelSoft website. At that time, you will be required to fill out a one-page fact sheet about your company.

3. An Expanded Executive Summary: Your expanded summary should be no more than 5 to 8 pages in length, including all graphs, charts, and tables, but not including the cover sheet or one-page fact sheet. All submissions should be either in MS Word or PDF formats.



 
Recent Articles
Venture Funding: Should Your Technology Firm Take the Leap?
by Blair Robsinson
Apr 27, 2013 | 0 0 comments | 5 5 recommendations | email to a friend
Ever since the the dot-com boom of the nineties, venture capital has been viewed as a prerequisite for the successful  growth of technology start-ups. But new companies should  -- and can afford to be -- leery of accepting venture funding. There's no doubt that funding is the lifeblood of business growth, but entrepreneurs shouldn't forget th...
DuPont Pioneer Announces Roll-Out of Global Genotypic Data Management System to Accelerate Agriculture Solutions for Farmers
Apr 09, 2013 | 0 0 comments | 3 3 recommendations | email to a friend
Utilizing UNIConnect Technology, DuPont Pioneer Laboratory Information Management System is Already Processing Millions of Data Points per Day
ThermImage To Receive SBIR Grant
Apr 01, 2013 | 0 0 comments | 3 3 recommendations | email to a friend
ThermImage, Inc., a Salt Lake City-based developer of medical devices, has been chosen to receive a Phase I Small Business Innovation Research Grant from the National Institutes of Health.
 
Entrepreneurial Assessment